Am J Physiol Renal Physiol 301(2):F355F363 Day JW, Ottaway N, Patterson JT, Gelfanov V, Smiley D, Gidda J et al (2009) A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
Full account creation is required upfront, which is the main friction
Limits on global production capacity mean that now only at most about 100 million people could receive the drugs only 10% of the 1 billion who could benefit
Common side effects include nausea, bloating, gas, constipation, diarrhea, or decreased appetite, especially when doses increase
While multivitamin supplements can't replace eating a wide variety of foods, they could be particularly beneficial to people with increased nutrient needs, such as those struggling to meet nutritional demands on a GLP-1 medication
Improves Recovery: Reduces muscle damage and supports faster recovery between workouts